Le Lézard
Classified in: Science and technology, Covid-19 virus

Population Health Management Market - Global Forecasts to 2026 - ResearchAndMarkets.com


The "Population Health Management Market by Component (Software, Services), Mode of Delivery (On-premise, Cloud-based), End User (Healthcare Providers, Healthcare Payers, Employer Groups, Government Bodies) COVID-19 Impact Analysis - Global Forecasts to 2026" report has been added to ResearchAndMarkets.com's offering.

The global population health management market is projected to reach USD 46.7 billion by 2026 from USD 24.9 billion in 2021, at a CAGR of 13.4%

In this report, the population health management market has been segmented on the basis of component, mode of delivery, end user, and region.

Population health management solutions enable stakeholders in the healthcare sector to deliver patient-centric care and help in curtailing the high costs associated with healthcare by reducing readmissions, ensuring that only appropriate and optimum interventions are provided to patients. These solutions streamline workflows by ensuring that the processes in care delivery function smoothly.

Government mandates and support for healthcare IT solutions, increasing use of big data analytics, and the need to curtail the escalating healthcare costs are the key factors driving the growth of the population health management market. In addition, the growth of emerging economies (such as Brazil, Russia, India, South Korea, and China), increasing focus on personalized medicine, and the rising focus on value-based medicine are expected to offer lucrative growth opportunities for market players during the forecast period. However, data breaches, lack of skilled analysts, and interoperability issues are adversely impacting the growth of this market.

The Software segment accounted for the largest market share in 2020.

On the basis of component, the population health management market has been segmented into software and services. In 2020, the software segment accounted for the largest share of the market. It is projected to reach USD 34.1 billion by 2026 from USD 17.7 billion in 2021, at a CAGR of 14.0%.

The dominance of this segment can be attributed to the increased adoption of software solutions by payers and providers to reduce readmissions, increase cost-effectiveness, improve operational efficiency, enhance patient engagement, and aid data integration and analysis.

The On Premise segment accounted for the largest market share in 2020.

Population health management solutions reach end users through the on-premise and/or cloud-based modes of delivery. The on-premise solutions segment accounted for the larger market share of 63.9% in 2020. The advantages offered by the on-premise mode of delivery, such as customization of solutions, reduction in the risk of data breaches, and the ability to reuse existing servers and storage hardware are supporting its increased adoption in the population health management market.

The Healthcare Providers segment accounted for the largest market share in 2020.

On the basis of end user, the population health management market is segmented into healthcare providers, healthcare payers, and other end users. In 2020, the healthcare providers segment accounted for the largest share of 67.0% of the population health management market.

The large share of this segment is attributed to the implementation of the Affordable Care Act and Hospital Readmissions Reduction Program (aimed at lowering healthcare costs by using novel population health management solutions) in the US, as well as the high demand for these solutions among healthcare providers across regions.

North America was the largest regional market for population health management market in 2020

North America accounted for the largest share of 75.1% of the global population health management market in 2020. Factors such as growing federal healthcare mandates to curb the rising healthcare costs, increasing regulatory requirements, growing adoption of EHRs, and rising government initiatives focusing on personalized medicine and value-based reimbursements are expected to drive market growth in North America.

The Asia Pacific market, comprising India, China, Japan, and the Rest of Asia Pacific, offers high-growth opportunities for market players. This regional segment is estimated to register the highest CAGR of 19.1% during the forecast period.

The growth of the Asia Pacific population health management market is driven by the rising medical tourism, the implementation of new ICT guidelines in Japan, investments and reforms to modernize China's healthcare infrastructure, the rapidly growing healthcare industry in India, and the implementation of IT programs in Australia and New Zealand.

In addition, government initiatives for the adoption of HCIT, the growing geriatric population, rising prevalence of chronic diseases, increasing healthcare expenditure, and the rising purchasing power of consumers are also expected to support market growth in this region.

Premium Insights

Market Dynamics

Drivers

Restraints

Opportunities

Challenges

Industry Insights

Industry Trends

COVID-19 Impact Analysis

Ecosystem

Evolution of Accountable Care Organizations (Acos): a Promising Payment Reform

HCIT Expenditure Analysis

Company Profiles

Key Players

Other Emerging Players

For more information about this report visit https://www.researchandmarkets.com/r/ee5c2d


These press releases may also interest you

at 07:55
The "KEYTRUDA Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering. The report provides comprehensive insights about KEYTRUDA for ovarian cancer in the seven major markets. A detailed...

at 07:50
The "Peptide Synthesis Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Type of Peptide Synthesis Method, Type of Chemical Synthesis, Contract Manufacturing Organization Size, Key Geographical Regions" report has been added to...

at 07:48
Arçelik, the world's leading manufacturer of household appliances, announced today it will rename its global operations under one international...

at 07:45
The "Laboratory Filtration Equipment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Laboratory Filtration Equipment Market to Reach $3 Billion by 2030 The global market for Laboratory...

at 07:42
Reference is made to Akastor ASA's (OSE: AKAST) announcement dated 18 April 2024 on the arbitration award issued in respect of the DRU contracts. Payment of the principal sums awarded, in total USD 108 million (exclusive interest), has now been...

at 07:40
The "Global Weight Loss Drugs Market: Analysis By Product Type, By Drug Type, By Distribution Channel, By End User, By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's...



News published on and distributed by: